CEOs from Medtronic, Boston Scientific, 3M, and more have called for deescalation in Minneapolis following two ICE-involved ...

Robert Kowal, MD, tells MD+DI how he became involved with the development of Medtronic's Micra leadless pacemaker.

A new survey reveals 20% of Gen Z use AI chatbots for STI/STD questions, but chatbots misdiagnose 31% of cases, raising ...

This week in Pedersen's POV, our senior editor examines AdvaMed's strategic approach to tariff discussions with the Trump ...

Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE ...

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Woori IO plans to accelerate its noninvasive CGM launch after FDA announced relaxed wearable device regulations.

Medtronic will invest $90M in Anteris Technologies for DurAVR TAVR device development, contingent on a $200M IPO.

Click Therapeutics’ CEO discusses the first FDA-cleared depression app, migraine treatment breakthrough, and digital ...

According to a June 1996 article in MD+DI, two surveys that year had pegged increased investments in information technologies ...

Michael “Mick” Farrell, chairman and CEO of Resmed, has begun his two-year term as the new chair of AdvaMed’s board of ...

This week's Medtech in a Minute features news about Boston Scientific and a potentially dangerous chemical used in IV bags ...